Polyprenylated Benzophenones from Brazilian Red Propolis: Analytical Characterization and Anticancer Activity

Loren M Pires,Mario F C Santos,Laisla R Figueiredo,Renata Faleiros,Fernanda R Badoco,Karolinne B Silva,Sérgio R Ambrósio,Jairo Kenupp Bastos,Raquel Alves Alves Santos,Rodrigo C S Veneziani
DOI: https://doi.org/10.1002/cbdv.202401288
2024-09-04
Abstract:The present work describes the extraction of a polyprenylated benzophenone-rich extract from Brazilian red propolis (ERPB), the development and validation of an RP-HPLC-UV method to characterize it, and its evaluation against breast cancer cell lines MCF-7 and MDA-MB-231, as well as the normal counterpart MCF-10A. A mixture of gutifferone E and xanthochymol (1+2), and isolated oblongifolin B (3) were used as chemical standards for ERPB and were also evaluated. The concentrations of 1+2 and 3 corresponded to 16.68% and 42.25% of the total content of the extract, respectively, and the validation parameters evaluated were satisfactorily met. The cytotoxic effects of ERPB were assessed, and the obtained IC50 values were 19.58 μg/mL (MCF-10A), 11.56 μg/mL (MCF-7), and 5.22 μg/mL (MDA-MB-231). In conclusion, ERPB exhibits promising cytotoxic effects on the tested breast cell lines. However, further investigation to elucidate its potential therapeutic applications and safety profile should be conducted.
What problem does this paper attempt to address?